Аннотация:
Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in clinical practice. Each year, the number of patients with AF significantly increases. It is associated with an increase of life expectancy and frequency of cardiovascular pathologies. Treatment of AF remains one of the most difficult tasks of modern cardiology. Currently, only a few antiarrhythmic drugs are available for use in Russia. More and more new attempts are being made to create a universal antiarrhythmic drug with a high level of anti-relapsing efficacy and adverse effects. The accumulated information suggests that the tactics of management of patients with arrhythmias will be intended to improving the new surgical and interventional treatment methods with use of anticoagulants and antiarrhythmic drugs. The multidisciplinary team of specialists on AF treatment should include an expert (cardiologist) in antiarrhythmic drug therapy, an interventional electrophysiologist, and a cardiac surgeon - mast
Ключевые слова:
Antiarrhythmic therapy; Atrial fibrillation; Treatment
antiarrhythmic agent; anticoagulant agent; ablation therapy; Article; atrial fibrillation; cardiac surgeon; cardiologist; clinical practice; drug efficacy; heart arrhythmia; heart rhythm; human; interventional cardiovascular procedure; life expectancy; multidisciplinary team
Подзолков В. И. Валерий Иванович 1948-
Тарзиманова А. И. Аида Ильгизовна 1978-
Podzolkov V. I. Valerij Ivanovich 1948-
Tarzimanova A. I. Aida Il`gizovna 1978-
Antiarrhythmic therapy in the treatment of atrial fibrillation: Yesterday, today, tomorrow [Антиаритмическая терапия в лечении фибрилляции предсердий: вчера, сегодня, завтра]
Antiarrhythmic therapy in the treatment of atrial fibrillation: Yesterday, today, tomorrow [Антиаритмическая терапия в лечении фибрилляции...
Текст визуальный непосредственный
Кардиоваскулярная терапия и профилактика
ООО "Силицея-Полиграф"
Т. 18, Вып. 3 С. 81-87
2019
Статья
Antiarrhythmic therapy Atrial fibrillation Treatment
antiarrhythmic agent anticoagulant agent ablation therapy Article atrial fibrillation cardiac surgeon cardiologist clinical practice drug efficacy heart arrhythmia heart rhythm human interventional cardiovascular procedure life expectancy multidisciplinary team
Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in clinical practice. Each year, the number of patients with AF significantly increases. It is associated with an increase of life expectancy and frequency of cardiovascular pathologies. Treatment of AF remains one of the most difficult tasks of modern cardiology. Currently, only a few antiarrhythmic drugs are available for use in Russia. More and more new attempts are being made to create a universal antiarrhythmic drug with a high level of anti-relapsing efficacy and adverse effects. The accumulated information suggests that the tactics of management of patients with arrhythmias will be intended to improving the new surgical and interventional treatment methods with use of anticoagulants and antiarrhythmic drugs. The multidisciplinary team of specialists on AF treatment should include an expert (cardiologist) in antiarrhythmic drug therapy, an interventional electrophysiologist, and a cardiac surgeon - mast